Autopsy report · NCT02070588

Advanced MRI Applications for Mild Traumatic Brain Injury

“Sponsor terminated early as moving to a new larger study program”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 1 year 9 months before it stopped.
• 112 participants enrolled.
• Results were posted on the registry 1 year 8 months after it ended.

Vital statistics

Status

Terminated

Phase

Na

Sponsor

GE Healthcare

Sponsor type

Industry

Conditions

Mild Traumatic Brain Injury; Traumatic Brain Injury

Interventions

MRI

Participants

112

Sites

1

Countries

United States

Trials that died the same way

• Open-Label Trial to Determine the Long-Term Safety of Safinamide in Parkinson's Disease Patients
  “study terminated early due to change in Sponsorship” (88% match in meaning)
• LIONS (PLK4 Inhibitor in Advanced Solid Tumors)
  “Sponsor decided to terminate study early” (86% match in meaning)
• TBI MR Study 3 Houston Methodist
  “Sponsor terminated study early to start a larger feasability study” (84% match in meaning)
• Ritlecitinib (PF-06651600) in Participants With Chronic Spontaneous Urticaria
  “Sponsor terminated study” (84% match in meaning)
• An Open-Label Extension Study to Evaluate Safety & Tolerability of QR-421a in Subjects With Retinitis Pigmentosa
  “The sponsor decided to terminate the study early” (82% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.